ANDRÉ DE TROYER, M.D.; WILLY PILLOY, M.D.; IVO BROECKAERT, M.D.; JEAN-CLAUDE DEMANET, M.D., PH.D.
This content is PDF only. Please click on the PDF icon to access.
The role of antidiuretic hormone (ADH) in the pathogenesis of fluid retention in cirrhosis of the liver remains unclear. The defect in water excretion in these patients probably represents defective formation of free water rather than its excessive reabsorption. Nevertheless recent measurement of plasma vasopressin levels with a highly sensitive radioimmunoassay revealed high or normal values in ascitic patients, even when hyponatremia was present (1). This suggests that ADH may be responsible, at least in part, for the abnormal water retention in patients with cirrhosis.
We report here the first study of the effect in such patients of demeclocycline, a tetracycline
DE TROYER A, PILLOY W, BROECKAERT I, DEMANET J. Demeclocycline Treatment of Water Retention in Cirrhosis. Ann Intern Med. ;85:336. doi: 10.7326/0003-4819-85-3-336
Download citation file:
Published: Ann Intern Med. 1976;85(3):336.
Gastroenterology/Hepatology, Liver Disease.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use